Form 4: Relay Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations

Brian Adams, Chief Legal Officer of Relay Therapeutics, sold shares to cover income tax withholding obligations related to vesting restricted stock units.

Summary

• Brian Adams, the Chief Legal Officer of Relay Therapeutics, sold shares of common stock on April 28, 2025, and April 30, 2025.
• The sales were executed to cover income tax withholding obligations upon the vesting of restricted stock units (RSUs).
• On April 28, 2025, 1,644 shares were sold at a price of $3.17 per share.
• On April 30, 2025, 12,943 shares were sold at a price of $3 per share.
• After these transactions, Adams beneficially owns 404,328 shares, including 234,902 shares underlying RSUs, and 391,385 shares, including 192,510 shares underlying RSUs, respectively.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales of shares by company executives to cover tax obligations upon vesting of stock options or RSUs are a common practice.

Stakeholder Impact

• The sale of shares by a company officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.

Key Dates

Keywords

Relay Therapeutics, Brian Adams, Chief Legal Officer, Form 4, Stock Sale, Restricted Stock Units, RSUs, Beneficial Ownership, Tax Obligations